ACE2 and COVID-19: The pathogen, SARS‐CoV‐2, enters the host through interaction with angiotensin‐converting enzyme 2 (ACE2) receptor expressed in pulmonary endothelium as well6, 7; thus, pulmonary vasculature is a possible target in COVID‐19.